Saudi licensee starts distributing Viraleze
TGA approval of Viraleze in Australia
AstraZeneca updates on two Azd0466 trials
FDA approval of NDA for Vivagel BV
Dep Gemcitabine enters phase 1/2 clinical trial
Starpharma disclose Faslodex as the drug they are working on in house
A new partner is disclosed
Merck initiates a Dep candidate into phase 1/2 ADC human trial
And Russian troops start to withdraw from Ukraine
Wishful thinking this coming week
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.005(4.55%) |
Mkt cap ! $47.38M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $33.06K | 289.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 158199 | 6 |
View Market Depth
| Last trade - 15.45pm 20/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.5¢ |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 11.3¢ | 11.5¢ | 11.0¢ | 195357 | ||
| Last updated 15.47pm 20/05/2024 ? | |||||
| SPL (ASX) Chart |